Activation Imaging Technology Enhances Cardiac Function Assessment
Activation Imaging Technology Enhances Cardiac Function Assessment
Toshiba’s new offering enhances cardiac function assessment
March 15, 2013
Toshiba echo activation image showing a color-coded map of where activation starts and ends during each contraction. This example shows a posterior lateral infarction timing defect.
For better treatment planning during cardiac resynchronization therapy (CRT), Toshiba America Medical System Inc.’s Activation Imaging is the company’s latest addition to its 3-D Wall Motion Tracking software. Activation Imaging is an U.S. Food and Drug Administration (FDA)-cleared, proprietary technology available on the Aplio Artida cardiovascular ultrasound system.
Activation Imaging, in conjunction with Toshiba’s comprehensive 3-D Wall Motion Tracking software, allows clinicians to evaluate dyssynchrony at the onset of the heart’s contraction and to properly identify the left ventricle’s pumping strength and timing for more accurate lead placements in CRT treatment.
For more information: www.medical.toshiba.com
